- Home
- LDTC vs DXR Comparison
LDTC vs DXR Comparison
Compare LDTC & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDTC
- DXR
- Stock Information
- Founded
- LDTC 2007
- DXR 1970
- Country
- LDTC Canada
- DXR United States
- Employees
- LDTC N/A
- DXR N/A
- Industry
- LDTC Blank Checks
- DXR Medical/Dental Instruments
- Sector
- LDTC Finance
- DXR Health Care
- Exchange
- LDTC Nasdaq
- DXR Nasdaq
- Market Cap
- LDTC 37.5M
- DXR 40.3M
- IPO Year
- LDTC N/A
- DXR N/A
- Fundamental
- Price
- LDTC $0.42
- DXR $7.65
- Analyst Decision
- LDTC Buy
- DXR Strong Buy
- Analyst Count
- LDTC 2
- DXR 1
- Target Price
- LDTC $3.00
- DXR $25.00
- AVG Volume (30 Days)
- LDTC 104.2K
- DXR 9.0K
- Earning Date
- LDTC 05-13-2025
- DXR 01-01-0001
- Dividend Yield
- LDTC N/A
- DXR N/A
- EPS Growth
- LDTC N/A
- DXR 86.16
- EPS
- LDTC N/A
- DXR 0.11
- Revenue
- LDTC $331,997.00
- DXR $119,714.00
- Revenue This Year
- LDTC $1,128.94
- DXR N/A
- Revenue Next Year
- LDTC $169.93
- DXR N/A
- P/E Ratio
- LDTC N/A
- DXR $72.86
- Revenue Growth
- LDTC 141.86
- DXR N/A
- 52 Week Low
- LDTC $0.22
- DXR $6.55
- 52 Week High
- LDTC $2.75
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- LDTC 33.16
- DXR 49.84
- Support Level
- LDTC $0.41
- DXR $8.02
- Resistance Level
- LDTC $0.64
- DXR $8.24
- Average True Range (ATR)
- LDTC 0.05
- DXR 0.37
- MACD
- LDTC -0.00
- DXR -0.05
- Stochastic Oscillator
- LDTC 6.04
- DXR 21.95
About LDTC LeddarTech Holdings Inc.
LeddarTech Holdings Inc is a company that develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. Its automotive-grade software applies AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for decision-making and safer navigation. The company generates the majority of its revenue from France, Canada, and the United states.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.